New digital technologies offer a different approach to capturing, analyzing and predicting patient behavior.
The influx of new digital technologies has offered the clinical trial industry a systemized approach to collect and analyze patient behavior
New digital technologies offer a centralized, standardized approach to capturing, analyzing and predicting patient behavior
EVERSANA, while being formed, realized that its customers needed patient-centered, value-based care
CVS’s objective is to place consumers at the center of its strategy and help them achieve their best health by strengthening health care locally and making it simpler to use and understand
Raising the Bar on performance So as to force companies to get lean, activist investors employ the use of shareholder arbitrage. There is increasing selection in licensing and partnering opportunities, and a reduced margin for error. Market-authorization for one-time results in periodic reevaluation throughout the life cycle of the product. There is relentlessness in the […]
The cost and time commitment to develop new drugs has increased significantly over the last few decades. A variety of factors come into play, but on average, in terms of total expenditures, it has taken from $3 to $5 billion and up to 15 years to bring a new drug to market. Even after all […]
The insurer-owned Allegheny Health Network is partnering with a national cancer center to offer new therapies and trials in western Pennsylvania, a sign of heightening regional competition and the emergence of new models for pursuing innovative treatments. Highmark’s Allegheny Health Network has signed a five-year affiliation contract with Johns Hopkins’ Kimmel Cancer Center to bring […]